Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel

BACKGROUND: The identification of driver mutations has greatly promoted the precise diagnosis and treatment of non-small cell lung cancer (NSCLC), but there is lack of targeted sequencing panels specifically designed and applied to Chinese NSCLC patients. This study aimed to design and validate of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Wu, Yang, Chen, Min-Jiang, Xu, Yan, Zhong, Wei, Wang, Meng-Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840037/
https://www.ncbi.nlm.nih.gov/pubmed/36647494
http://dx.doi.org/10.21037/jtd-22-909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840037/
https://www.ncbi.nlm.nih.gov/pubmed/36647494
http://dx.doi.org/10.21037/jtd-22-909

Ejemplares similares